Vivani Medical Inc VANI

$1.02 +0.01 (0.99%)

Valuation

Market cap
91,105,000
Revenue TTM
$0
Net income TTM
$-26,610,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
461,100
Avg volume
229,658
Day's range
$1.01 – $1.11
Shares out
90,203,000
Stochastic %K
61%
Beta
2.51
Analysts
Strong Buy
Price target
$3.83

Price

Company profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic d...

Show more

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.

Industry
Biotechnology
Sector
Healthcare
Phone
415 506 8462
Website
https://www.vivani.com
Address
1350 South Loop Road, Alameda, United States

Latest news

Stocktwits

DilutionScan Nov 16, 9:40 PM
$VANI filed an 8-K with Item 3.02, unregistered sales of equity (accepted 4:30 PM ET). That item is where PIPEs, warrant issuances and convertible notes usually show up.
0 replies
juliano777 Nov 16, 12:29 PM
$VANI You should do the same as the insiders. These new shares represent 5.5% of the existing capital. Consider also increasing your position by 5.5% so as not to be diluted.
0 replies
wolfcyd3 Nov 16, 12:18 PM
$VANI insiders buying again and now funded until the 3rd quarter 2027. Seems like a good entry at this price
0 replies
focafoca99 Nov 16, 10:40 AM
$VANI raised about $5.1 million in a private placement of 5 M shares at $1.01 each to fund its NPM-139 implant program. https://www.rapidticker.com/news/vani-vivani-medical-announces-private-placement-bd16fd
0 replies
Rayvio_News_Filter Nov 16, 10:31 AM
$VANI 💰 Vivani Medical, Inc. announced a private placement of 5,049,506 shares at $1.01 per share purchased by board members Gregg Williams and Aaron Mendelsohn for gross proceeds of approximately $5.1 million. Prioritized by relevance More market highlights: https://rayvio.app/dashboard/?utm_source=lifatpt
0 replies
ShortSqueezeHQ Nov 16, 12:00 AM
$VANI $VKTX $MDXH $LLY Squeeze em
0 replies
AlertsAndNews Nov 15, 11:42 PM
$VANI insider action here Donald Dwyer (Chief Business Officer) Buys 20,000 @ $0.98 Avg
1 replies
BC322032 Nov 14, 2:55 AM
$VANI BOOM - More insider buying!!
1 replies